Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sadahiro Koinumaru"'
Autor:
Toshihiro Nukiwa, M. Kanbe, Yasuo Saijo, N. Matsubara, Kazunori Gomi, Kazuhiro Usui, Akira Inoue, Masashi Tanaka, Osamu Ishimoto, Sadahiro Koinumaru
Publikováno v:
Lung Cancer. 52:83-87
We conducted this phase II study to explore the efficacy and safety of weekly paclitaxel combined with carboplatin in elderly patients with advanced non-small cell lung cancer (NSCLC). Elderly patients (> or = 70 years old) of stage IIIB, IV, or recu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d991a2804c6273039fd8775decfbb8
https://doi.org/10.1016/j.lungcan.2005.11.014
https://doi.org/10.1016/j.lungcan.2005.11.014
Autor:
Yoshio Yamane, Junichi Saito, Yasuo Saijo, Yushi Nakai, Tomei Tsukamoto, Tsuneo Sayama, Sadahiro Koinumaru, Noboru Aso, Takehito Nakabayashi, Toshihiro Nukiwa, Yoshifumi Matsuura
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 31(2-3)
Based on the results of our previous pilot study, we conducted a multi-institutional phase II study of combination chemotherapy consisting of oral UFT (Taiho Pharmaceutical Co. Ltd, Tokyo) plus cisplatin (CDDP) in patients with advanced non-small cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515363c52e3f11a299bc373a3b53e35c
https://pubmed.ncbi.nlm.nih.gov/11165409
https://pubmed.ncbi.nlm.nih.gov/11165409
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 18(3)
Combined use of 5-fluorouracil (5-FU) and cisplatin has proven to have synergistic effects in many experimental systems and clinical studies. UFT, an oral preparation of uracil and tegafur in a 4:1 molar ratio, was reported to have enhanced activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e40485fa73c2ff8d6770cab31904b7
https://pubmed.ncbi.nlm.nih.gov/9444649
https://pubmed.ncbi.nlm.nih.gov/9444649
Autor:
N. Matsubara, Junichi Saito, Yushi Nakai, Masakichi Motomiya, Shunichi Sugawara, Shuji Suzuki, Sadahiro Koinumaru, Joji Sato, Yuka Numata
Publikováno v:
The Tohoku journal of experimental medicine. 168(2)
NAKAI, Y., KOINUMARU, S., SUZUKI, S., SAITO, J., SUGAWARA, S., NUMATA, Y., SATO, J., MATSUBARA, N. and MOTOMIYA, M. Chemotherapy in Small Cell Lung Cancer - From View Point of Dose Intensity - Tohoku J. Exp. Med., 1992, 168 (2), 427-430 - Results of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841d6af88eb7bdee6703155cc5a9de4d
https://pubmed.ncbi.nlm.nih.gov/1339106
https://pubmed.ncbi.nlm.nih.gov/1339106
Autor:
Yasuo Saijo, Akira Inoue, Osamu Ishimoto, Shunichi Sugawara, Y. Haseaawa, Toshiro Suzuki, Toshihiro Nukiwa, Sadahiro Koinumaru, H. Miki, Takashi Ishida
Publikováno v:
Lung Cancer. 49:S391
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d88afaf1f32e1d4cf0b1361dbff17f0
https://doi.org/10.1016/s0169-5002(05)81517-x
https://doi.org/10.1016/s0169-5002(05)81517-x
Autor:
N. Matsubara, M. Kanbe, Kazunori Gomi, Osamu Ishimoto, Sadahiro Koinumaru, M. Tanaka, Yasuo Saijo, Toshihiro Nukiwa, Kazuhiro Usui, Akira Inoue
Publikováno v:
Journal of Clinical Oncology. 23:7248-7248
7248 Background: Paclitaxel combined with carboplatin (PC) is a commonly used regimen in advanced NSCLC. Although some studies suggested that PC is also effective for elderly patients, weekly pacli...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96a81abbc13aad6cc0b9984153aa3ed7
https://doi.org/10.1200/jco.2005.23.16_suppl.7248
https://doi.org/10.1200/jco.2005.23.16_suppl.7248
Autor:
Takashi Matsuda, Toshihiro Nukiwa, Sadahiro Koinumaru, Junichi Saito, Yushi Nakai, Yasuo Saijo
Publikováno v:
Lung Cancer. 29:69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a446613420deffc97d2feeccfb485fe
https://doi.org/10.1016/s0169-5002(00)80224-x
https://doi.org/10.1016/s0169-5002(00)80224-x
Autor:
Nobuko Kumano, Shunichi Sugawara, Kotaro Oizumi, Yasuo Saijo, Masakichi Motomiya, Shuji Suzuki, Sadahiro Koinumaru
Publikováno v:
The Tohoku Journal of Experimental Medicine. 157:215-219
A VP-16-resistant subline was established from THP-1 human monocytic leukemia cells by subculturing in stepwise increasing concentrations of the drug. The resistant cells (THP-1/E) were capable of sustaining continuous growth in 1.0 microgram/ml VP-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cded1fb12f51d5e9cc0e5e73d7a2350b
https://doi.org/10.1620/tjem.157.215
https://doi.org/10.1620/tjem.157.215
Autor:
Tomoyoshi Kikumoto, Tetsuko Ishikawa, Kiyoshi Konno, Yushi Nakai, Nobuko Kumano, Shuji Suzuki, Sadahiro Koinumaru
Publikováno v:
The Tohoku Journal of Experimental Medicine. 146:97-104
Effects of the organogermanium compound Ge-132 (i.p.) were examined on the 3LL local tumor (1 X 10(5)/mouse, s.c.) and its pulmonary metastases in B6 mice. A characteristic feature of its action was the preferential antimetastatic effect under strict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::407719e6a503b2a5b5181a72ffbeced2
https://doi.org/10.1620/tjem.146.97
https://doi.org/10.1620/tjem.146.97
Autor:
Tetsuko Ishikawa, Yushi Nakai, Kiyoshi Konno, Tomoyoshi Kikumoto, Nobuko Kumano, Shuji Suzuki, Sadahiro Koinumaru
Publikováno v:
The Tohoku Journal of Experimental Medicine. 134:401-409
Prophylaxis of 3-methylcholanthrene-induced epithelial tumor formation in ddI mice with our Candida utilis glucomannan preparation (YPS) was confirmed further in the present system of fibrosarcoma production. A single subcutaneous dose of MCA (0.5 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62da05e0f46401a6642f349d249dd1ae
https://doi.org/10.1620/tjem.134.401
https://doi.org/10.1620/tjem.134.401